Basilea Pharmaceutica Ltd. Logo
 
Malta
 
 

General Contact

Basilea Pharmaceutica International Ltd.
Grenzacherstr. 487
PO Box
4005 Basel
Switzerland
T: +41 61 606 11 11
F: +41 61 606 11 12

 

Medical Information

T: +41 61 606 1400
F: +41 61 606 1216
 
 

Drug Safety

T: +41 61 606 1401
F: +41 61 606 1312

 

Product Information

Toctino® (alitretinoin) is licensed in Malta as an oral treatment for patients suffering from severe chronic hand eczema that does not respond to potent topical corticosteroid therapy. However it is not currently distributed.
Toctino® (alitretinoin) is a naturally occurring, physiologic derivative of vitamin A and belongs to the well studied family of retinoids, which are all teratogens; therefore, Toctino® (alitretinoin) is strictly contraindicated in women of child-bearing potential unless strict pregnancy testing and contraception is followed before, during and one month after cessation of treatment.
The following pages are intended for people who wish to find out more about the Pregnancy Prevention Programme (PPP).
Please also consult the Toctino® (alitretinoin) Summary of Product Characteristics and the Toctino® (alitretinoin) Patient Information Leaflet for further details.

 
SmPC MT [189 kb]

Show General Disclaimer
Info